Tenet Healthcare price target raised to $147 from $113 at Barclays

Barclays analyst Andrew Mok raised the firm’s price target on Tenet Healthcare to $147 from $113 and keeps an Overweight rating on the shares post the Q1 report. Despite a sizable guidance raise, Barclays still sees meaningful upside and another Q2 guidance raise.